DAVID ADELSTEIN, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1922061365Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

35040877A(OH)

Research & Publications (20)

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).

PMID 19557750·Head Neck·2010

3-trial

Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.

PMID 19668013·J Thorac Oncol·2009

3-trial

Current and emerging standards of concomitant chemoradiotherapy.

PMID 18544436·Semin Oncol·2008

6-review

Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions.

PMID 17848289·Int J Radiat Oncol Biol Phys·2007

8-other

A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.

PMID 17414467·Am J Clin Oncol·2007

3-trial

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.

PMID 16505425·J Clin Oncol·2006

8-other

Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?

PMID 16763275·J Clin Oncol·2006

6-review

Oropharyngeal cancer: the role of chemotherapy.

PMID 12525275·Curr Treat Options Oncol·2003

6-review

Systemic chemotherapy for squamous cell head and neck cancer.

PMID 14640914·Expert Opin Pharmacother·2003

6-review

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

PMID 12506176·J Clin Oncol·2003

3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address: 9500 EUCLID AVE
CLEVELAND, OH 44195
Phone: (800) 223-2273

Quick Facts

NPI: 1922061365
Entity Type: Individual
Gender: Male
Medicare: Not confirmed
Specialties: 1
Locations: 1
Publications: 20

Are you this provider?

Claim Your Profile